Skeletal accumulation of fluorescently-tagged zoledronate is higher in animals with early stage chronic kidney disease

Authors
Publication date
11 June 2018
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    This work examines the skeletal accumulation of fluorescently-tagged zoledronate in an animal model of chronic kidney disease. The results show higher accumulation 24-hours post-dose in animals with lower kidney function due to greater amounts of binding at individual surfaces.NIH F30 DK115162; NIH T32 AR065971; NIH P30 DK 07931

      Similar works

      Full text

      thumbnail-image

      Available Versions

      IUPUIScholarWorks

      redirect
      oaioai:scholarworks.indianapolis....
      Last time updated on 06/08/2024

      Crossref

      redirect
      oaiinfo:doi/10.1007%2Fs00198-018-...
      Last time updated on 11/12/2019

      ScholarWorks IU Indianapolis

      redirect
      oaioai:scholarworks.indianapolis....
      Last time updated on 15/06/2025

      IUPUIScholarWorks

      redirect
      oaioai:scholarworks.iupui.edu:180...
      Last time updated on 22/08/2019